Cargando…

Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma

Similar to other malignancies, urothelial carcinoma (UC) is characterized by specific recurrent chromosomal aberrations and gene mutations. However, the interconnection between specific genomic alterations, and how patterns of chromosomal alterations adhere to different molecular subgroups of UC, is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lindgren, David, Sjödahl, Gottfrid, Lauss, Martin, Staaf, Johan, Chebil, Gunilla, Lövgren, Kristina, Gudjonsson, Sigurdur, Liedberg, Fredrik, Patschan, Oliver, Månsson, Wiking, Fernö, Mårten, Höglund, Mattias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369837/ https://www.ncbi.nlm.nih.gov/pubmed/22685613 http://dx.doi.org/10.1371/journal.pone.0038863

Ejemplares similares

DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status
por: Lauss, Martin, et al.
Publicado: (2012)

A Systematic Study of Gene Mutations in Urothelial Carcinoma; Inactivating Mutations in TSC2 and PIK3R1
por: Sjödahl, Gottfrid, et al.
Publicado: (2011)

Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors
por: Heidenblad, Markus, et al.
Publicado: (2008)

HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts
por: Eriksson, Pontus, et al.
Publicado: (2017)

Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma
por: Sjödahl, Gottfrid, et al.
Publicado: (2019)

Recurring urothelial carcinomas show genomic rearrangements incompatible with a direct relationship
por: Marzouka, Nour-Al-Dain, et al.
Publicado: (2020)

Molecular classification of urothelial carcinoma: global mRNA classification versus tumour‐cell phenotype classification
por: Sjödahl, Gottfrid, et al.
Publicado: (2017)

Recurrent and multiple bladder tumors show conserved expression profiles
por: Lindgren, David, et al.
Publicado: (2008)

Detailed Analysis of Focal Chromosome Arm 1q and 6p Amplifications in Urothelial Carcinoma Reveals Complex Genomic Events on 1q, and SOX4 as a Possible Auxiliary Target on 6p
por: Eriksson, Pontus, et al.
Publicado: (2013)

Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems
por: Eriksson, Pontus, et al.
Publicado: (2015)

Molecular pathology of the luminal class of urothelial tumors
por: Bernardo, Carina, et al.
Publicado: (2019)

Molecular subtype classification of urothelial carcinoma in Lynch syndrome
por: Therkildsen, Christina, et al.
Publicado: (2018)

A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort
por: Marzouka, Nour-al-dain, et al.
Publicado: (2018)

Biological determinants of bladder cancer gene expression subtypes
por: Aine, Mattias, et al.
Publicado: (2015)

Low Frequency of Intratumor Heterogeneity in Bladder Cancer Tissue Microarrays
por: Jakobsson, Lovisa, et al.
Publicado: (2018)

Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma
por: Aine, Mattias, et al.
Publicado: (2015)

Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer—A Narrative Review
por: Sjödahl, Gottfrid, et al.
Publicado: (2022)

Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing: A Systematic Review
por: Medle, Benjamin, et al.
Publicado: (2022)

A comparison of rule-based and centroid single-sample multiclass predictors for transcriptomic classification
por: Eriksson, Pontus, et al.
Publicado: (2021)

An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells
por: Holm, Karolina, et al.
Publicado: (2016)

Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios
por: Staaf, Johan, et al.
Publicado: (2008)

The Urothelial Transcriptomic Response to Interferon Gamma: Implications for Bladder Cancer Prognosis and Immunotherapy
por: Baker, Simon C., et al.
Publicado: (2022)

Urodrill - a novel MRI-guided endoscopic biopsy technique to sample and molecularly classify muscle-invasive bladder cancer without fractionating the specimen during transurethral resection
por: Eriksson, Pontus, et al.
Publicado: (2023)

Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays
por: Staaf, Johan, et al.
Publicado: (2008)

Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors
por: Sjöström, Martin, et al.
Publicado: (2018)

Robust assignment of cancer subtypes from expression data using a uni-variate gene expression average as classifier
por: Lauss, Martin, et al.
Publicado: (2010)

Genome methylation patterns in male breast cancer – Identification of an epitype with hypermethylation of polycomb target genes
por: Johansson, Ida, et al.
Publicado: (2015)

Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
por: Olah, Csilla, et al.
Publicado: (2022)

Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer
por: Alkner, Sara, et al.
Publicado: (2016)

Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men
por: Teleka, Stanley, et al.
Publicado: (2022)

The Prognostic Role of Intratumoral Stromal Content in Lobular Breast Cancer
por: Forsare, Carina, et al.
Publicado: (2022)

Monitoring of Technical Variation in Quantitative High-Throughput Datasets
por: Lauss, Martin, et al.
Publicado: (2013)

Fast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective: results from a prospective intervention study
por: Liedberg, Fredrik, et al.
Publicado: (2016)

The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast
por: Narbe, Ulrik, et al.
Publicado: (2019)

Genomics and Immunomics in the Treatment of Urothelial Carcinoma
por: Mollica, Veronica, et al.
Publicado: (2022)

Performance of gene expression–based single sample predictors for assessment of clinicopathological subgroups and molecular subtypes in cancers: a case comparison study in non-small cell lung cancer
por: Cirenajwis, Helena, et al.
Publicado: (2019)

Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression
por: Jørgensen, Charlotte Levin Tykjær, et al.
Publicado: (2020)

Genomic profiling of Chinese patients with urothelial carcinoma
por: Yang, Bo, et al.
Publicado: (2021)

Distinct evolutionary mechanisms for genomic imbalances in high-risk and low-risk neuroblastomas
por: Gisselsson, David, et al.
Publicado: (2007)

Independent component analysis reveals new and biologically significant structures in micro array data
por: Frigyesi, Attila, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_dqumul8a24eru1rp94pldde228